These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32610150)

  • 1. Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer.
    Wu WK; Ivanova EA; Orekhov AN
    Semin Cancer Biol; 2021 May; 70():85-97. PubMed ID: 32610150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy.
    Chattopadhyay I; Nandi D; Nag A
    Semin Cancer Biol; 2021 May; 70():98-111. PubMed ID: 32739479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics in microbiome ecological balance providing a therapeutic window against cancer.
    Sehrawat N; Yadav M; Singh M; Kumar V; Sharma VR; Sharma AK
    Semin Cancer Biol; 2021 May; 70():24-36. PubMed ID: 32574811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota and Its Metabolites in Atherosclerosis Development.
    Pieczynska MD; Yang Y; Petrykowski S; Horbanczuk OK; Atanasov AG; Horbanczuk JO
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota.
    Zhao X; Oduro PK; Tong W; Wang Y; Gao X; Wang Q
    Pharmacol Res; 2021 Jan; 163():105362. PubMed ID: 33285231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
    Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S
    Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human gut microbiome - a new and exciting avenue in cardiovascular drug discovery.
    Du Y; Li X; Su C; Wang L; Jiang J; Hong B
    Expert Opin Drug Discov; 2019 Oct; 14(10):1037-1052. PubMed ID: 31315489
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis.
    Vourakis M; Mayer G; Rousseau G
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
    Liu X; Cao S; Zhang X
    J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
    Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases.
    Sanchez-Rodriguez E; Egea-Zorrilla A; Plaza-Díaz J; Aragón-Vela J; Muñoz-Quezada S; Tercedor-Sánchez L; Abadia-Molina F
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics.
    Inamura K
    Semin Cancer Biol; 2021 May; 70():11-23. PubMed ID: 32580023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota and Atherosclerosis.
    Li DY; Tang WHW
    Curr Atheroscler Rep; 2017 Aug; 19(10):39. PubMed ID: 28842845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet and cancer risk reduction: The role of diet-microbiota interactions and microbial metabolites.
    Weir TL; Trikha SRJ; Thompson HJ
    Semin Cancer Biol; 2021 May; 70():53-60. PubMed ID: 32574813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-fiber diets attenuate emphysema development via modulation of gut microbiota and metabolism.
    Jang YO; Kim OH; Kim SJ; Lee SH; Yun S; Lim SE; Yoo HJ; Shin Y; Lee SW
    Sci Rep; 2021 Mar; 11(1):7008. PubMed ID: 33772084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the microbiome for human health: from basic science to clinical applications.
    Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
    Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiome dysbiosis in cancer: Exploring therapeutic strategies to counter the disease.
    Sharma VR; Singh M; Kumar V; Yadav M; Sehrawat N; Sharma DK; Sharma AK
    Semin Cancer Biol; 2021 May; 70():61-70. PubMed ID: 32693015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.